Intra-arterial clot-busting medicines don’t help after stroke thrombectomy
UC expert featured in TCTMD article
The University of Cincinnati's Pooja Khatri, MD, spoke with TCTMD about two recent trials that found administering clot-busting medications after endovascular thrombectomy does not significantly improve outcomes for patients with acute ischemic stroke. Thrombectomy is a minimally invasive stroke procedure that uses a catheter to remove a blood clot from a blood vessel in the brain to restore blood flow.
These results come after a previous trial found a large and significant benefit in administering a medication called alteplase after successful thrombectomy.
Khatri, professor, vice chair of research and division chief in the Department of Neurology and Rehabilitation Medicine at UC's College of Medicine, associate director of the UC Gardner Neuroscience Institute and codirector of NIH StrokeNet’s National Coordinating Center, who was not involved in any of the trials, said the original trial was a smaller study that ended prematurely and included patients with a wider range of results after thrombectomy.
These newer data “are promising in terms of a therapeutic strategy with thrombolysis to attack distal visualized clots and maybe impaired microcirculatory reperfusion, or the no-reflow phenomenon as we like to call it,” she said, adding, however, that “I’m disappointed that the potential effect isn’t bigger.”
Featured photo at top of UC Health's mobile stroke unit courtesy of UC Health.
Remember how to identify a stroke
Because of the quick onset of stroke, it is important to know the FAST mnemonic device that details the most common signs of stroke and how to respond:
- F: Facial drooping
- A: Arm or leg drop, or weakness in the arm or leg
- S: Speech issues, such as slurred speech or an inability to get your words out
- T: Time is of the essence; call 911 immediately
Related Stories
Pocket-sized population threat
June 10, 2026
The Financial Times took a deep dive into why populations around the world continue to be on the decline. The publication cited new University of Cincinnati research as part of the investigation that looks at the fall of fertility in the digital era.
Patients with developmental disabilities may benefit with an integrated care model
June 9, 2026
Researchers from the University of Cincinnati and Ohio State University have found that adults with developmental disabilities who have integrated care were less likely to go to the emergency room or be hospitalized than others who were not. Their work was published in Disability and Health Journal.
UC physician-researcher's work yields landmark five-year data for Crohn's disease drug
June 8, 2026
The University of Cincinnati College of Medicine’s Anita Afzali, MD, leads a landmark study revealing five-year efficacy and safety data for a Crohn’s disease drug called guselkumab.